Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

In vivo Nanosensors for Diagnostics (IVN:Dx)

Solicitation Number: DARPA-BAA-12-33
Agency: Other Defense Agencies
Office: Defense Advanced Research Projects Agency
Location: Contracts Management Office
  • Print
Added: Mar 15, 2012 10:10 am
The specific objective of the In vivo Nanoplatforms for Diagnostics (IVN:Dx) thrust of the In vivo Nanoplatforms (IVN) program is to develop biocompatible nanosensors that provide continuous, noninvasive, and highly accurate measurement of a variety of conditions and substances within the living tissue of animals, plants, and insects using non-toxic materials with limited immunogenicity. These sensors will permit qualitative and quantitative assessment over large concentration ranges of both small (e.g., glucose, lactate, and urea) and large molecules (e.g., proteins, oligonucleotides, infectious agents, and chemical/biological threat agents) in the organism and environment through optical, electronic, thermal or magnetic mechanisms.

See the attached DARPA-BAA-12-33 document.

Please consult the list of document viewers if you cannot open a file.

DARPA-BAA-12-33 document

Other (Draft RFPs/RFIs, Responses to Questions, etc..)
DARPA-BAA-12-33 document
Posted Date:
March 15, 2012
Description: DARPA-BAA-12-33 document
Description: Approved Proposer Checklist
3701 North Fairfax Drive
Arlington, Virginia 22203-1714
Dr. Timothy Broderick